Professor Tomáš Hanke‘s research aims to develop a universal HIV-1 vaccine, which targets most global virus variants including escape mutants. He strives to maintain a balance between basic and translational research.
Prof. Hanke is a Professor of Vaccine Immunology at University of Oxford, Distinguished Professor at Kumamoto University, Jenner Investigator, Group Head / PI, Member of congregation and Supervisor.
The long term aim for Professor Tomáš Hanke is to develop a safe, effective and accessible HIV-1 vaccine. His group tests novel ideas and vaccine strategies, and focusses on a safe but rapid translation of the most promising laboratory results to phase I/II clinical trials in human volunteers.